Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
Use this TARS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TARS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TARS SEC filings page. Lician reads the product cache first so this HTML stays unique to Tarsus Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full TARS income, balance, and cash tables.